12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fycompa perampanel regulatory update

The European Commission approved an MAA from Eisai for Fycompa perampanel as an adjunctive therapy for partial-onset seizures in epilepsy patients 12...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >